A Flurry of Drug Recalls Hits Indian Pharma Firms in U.S.

☞ | View the full content of this post. Exclusively available to ASQ Members.

Indian generic drug manufacturers continue to recall high blood pressure medicines from the U.S. market after the key ingredients used in the drugs were detected with probable cancer-causing impurity.

In a latest, Ahmedabad-based Torrent Pharmaceuticals said it is expanding its voluntary recall of hypertension drug Losartan potassium tablets USP to a total of 10 lots due to detection of trace amounts of an unexpected impurity, N-nitrosodiethylamine (NDEA), found in an active pharmaceutical ingredient (API). Earlier in

☞ | View the full content of this post. Exclusively available to ASQ Members.

Leave a Comment

Your email address will not be published. Required fields are marked *